Business & regional news

After three years, most insulin was delivered automatically by the system, and those who used the recommended optimal settings experienced the greatest benefits.

Medtronic Smart MDI system includes unique early notification feature for missed meal boluses and high glucose that enables users to bolus on time. Consistent response to these notifications was associated with Time in Range of 67% and 71%, respectively.

The company will present clinical evidence at ATTD exploring challenges faced by women living with type 1 diabetes, from menstruation to pregestational diabetes

With its Meal Detection Technology™* and autocorrections every 5 minutes, Medtronic is expanding outcomes to populations in Asia and empowering patients to achieve greater glycemic control, especially during mealtimes.

New data from Australia, Japan, India, Singapore, Hong Kong, and South Korea demonstrates the MiniMed™ 780G is driving consistent clinical outcomes in diabetes management.

The company will present clinical evidence in young children, pregnancy and type 2 diabetes*

Dr. Petrovski’s expertise will further strengthen Medtronic clinical and scientific activities to help people with diabetes live better with technology

Medtronic will present the latest data on its MiniMed™ 780G insulin pump and showcase the company’s latest CareLink™ experience launching globally this month